Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16202909 | 1.00 | KDM4E (0.37) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL14728169 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL18505019 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL31862 | 0.94 | KDM4E (0.40) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL31739 | 0.93 | KDM4E (0.39) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL11922056 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL31695 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL14330763 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL8928270 | 0.93 | KDM4E (0.41) | KDM4EATML3MBTL1PDK2PGR | |
| SCHEMBL16204649 | 0.92 | KIF11 (0.34) | KDM4EATML3MBTL1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9017829-B2 | Phenanthrocarbazole compound, and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2015-04-28 | — | — | US | disclosed |
| US-9017829-B2 | Phenanthrocarbazole compound, and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2015-04-28 | — | — | US | disclosed |
| US-20130048975-A1 | PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048975-A1 | PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | DOOSAN CORPORATION (KR) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048975-A1 | PHENANTHROCARBAZOLE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | PPOX, ORC3, CACNA2D3 | KDM4E 1626/4885ATM 4087/4885L3MBTL1 2318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.